K. M. Flegal, M. D. Carrol, C. L. Ogden, and C. L. Johnson, Prevalence and trends in obesity among US adults 1999–2000, JAMA
, 1723–1727 (2002).PubMedCrossRef
J. B. Vincent, The bioinorganic chemistry of chromium(III), Polyhedron
, 1–26 (2001).CrossRef
J. B. Vincent, Elucidating a biological role for chromium at a molecular level, Acc. Chem. Res.
, 503–510 (2000).PubMedCrossRef
H. C. Lukaski, Chromium as a supplement, Annu. Rev. Nutr.
, 279–301 (1999).PubMedCrossRef
G. W. Evans, The effect of chromium picolinate on insulin controlled parameters in humans, Int. J. Biosoc. Med. Res.
11, 163–180 (1989).
G. R. Kaats, J. A. Wise, K. Blum, et al., The short-term therapeutic efficacy of treating obesity with a plant of improved nutrition and moderate calorie restriction, Curr. Ther. Res.
51, 261–274 (1992).
G. R. Kaats, K. Blum, J. A. Fisher, and J. A. Adelman, Effects of chromium picolinate supplementation on body composition: a randomized double-masked placebo-controlled study, Curr. Ther. Res.
, 747–756 (1996).CrossRef
R. Bulbulian, D. D. Pringle, and M. S. Liddy, Chromium picolinate supplementation in male and female swimmers, Med. Sci. Sport. Exerc.
28(5 Suppl.), S111 (1996).
B. Bahadori, S. Wallner, H. Schneider, T. C. Wascher, and H. Topak, Effects of chromium yeast and chromium picolinate on body composition in obese non-diabetic patients during and after a very low-calorie diet, Acta Med. Austr.
24, 185–187 (1997) (in German).
S. P. Clancy, P. M. Clarkson, M. E. DeCheke, et al., Effects of chromium picolinate supplementation on body composition, strength and urinary chromium loss in football players, Int. J. Sport Nutr.
, 142–153 (1994).PubMed
L. K. Trent and D. Thielding-Canel, Effects of chromium picolinate on body composition, J. Sports Med. Phys. Fitness
, 273–280 (1995).PubMed
H. C. Lukaski, W. Bolonchuk, W. A. Siders, and D. B. Milne, Chromium supplementation and resistance training: effects on body composition, strength, and trace element status of men, Am. J. Clin. Nutr.
, 954–965 (1996).PubMed
M. A. Hallmark, T. H. Reynolds, C. A. DeSouza, C. G. Dotson, R. A. Anderson, and M. A. Rogers, Effects of chromium on resistance training on muscle strength and body composition, Med. Sci. Sports Exerc.
, 139–144 (1996).PubMedCrossRef
W. J. Pasman, M. S. Westerperp-Plantenga, and W. H. M. Saris, The effectiveness of long-term supplementation of carbohydrate, chromium, fibre, and caffeine on weight maintenance, Int. J. Obes. Related Metab. Disord.
, 1143–1151 (1997).CrossRef
W. W. Campbell, L. J. Joseph, S. L. Davey, D. Cyr-Campbell, R. A. Anderson, and W. J. Evans, Effects of resistance training and chromium picolinate on body composition and skeletal muscle in older men, J. Appl. Physiol.
, 29–39 (1999).PubMed
R. I. Press, J. Geller, and G. W. Evans, The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects, West. J. Med.
, 41–45 (1990).PubMed
R. B. Krieder, R. Klesges, K. Harmon, et al., Effects of ingesting supplements designed to promote lean muscle tissue accretion on body composition during resistance training, Int. J. Sports Nutr., 6, 234–246 (1996).
J. B. Vincent, The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle development agent, Sports Med.
, 213–230 (2003).PubMedCrossRef
M. H. Pittler, C. Stevinson, and E. Ernst, Chromium picolinate for reducing body weight: meta-analysis of randomized trials, Int. J. Obes.
, 522–529 (2003).CrossRef
S. L. Nissen, and R. L. Sharp, Effect of dietary supplements on lean mass and strength gains with resistance exercise: a meta-analysis, J. Appl. Physiol.
, 651–659 (2003).PubMed
B. J. Clodfelder, B. M. Gullick, H. C. Lukaski, Y. Neggers, and J. B. Vincent, Oral administration of the biomimetic [Cr3
increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats, J. Biol. Inorg. Chem.
, 119–130 (2005).PubMedCrossRef
B. J. Clodfelder, C. Chang, and J. B. Vincent, Absorption of the biomimetic chromium cation triaqua-µ3
-oxo-triaqua-µ-hexapropionatotrichromium(III) in rats, Biol. Trace Element Res.
, 159–169 (2004).CrossRef
K. L. Olin, D. M. Stearns, W. H. Armstrong, and C. L. Keen, Comparative retention/absorption of 51chromium (51Cr) from 51Cr chloride, 51Cr nicotinate and 51Cr picolinate in a rat model, Trace Elements Electrolytes
11, 182–186 (1994).
R. A. Anderson, N. A. Bryden, M. M. Polansky, and K. Gauteschi, Dietary chromium effects on tissue chromium concentrations and chromium absorption in rats, J. Trace Elements Exp. Med.
, 11–25 (1996).CrossRef
C. Sun, W. Zhang, S. Wang, and Y. Zhang, Effect of chromium gluconate on body weight, serum leptin and insulin in rats, Wei Sheng Yan Jiu
, 370–371 (2000) (in Chinese).PubMed
S. Wang, C. Sun, Q. Kao, and C. Yu, Effects of chromium and fish oil on insulin resistance and leptin resistance in obese developing rats, Wei Sheng Yan Jiu
, 284–286 (2001) (in Chinese).PubMed
B. M. Gullick, Ph.D. dissertation, The University of Alabama, Tuscaloosa (2005).
A. Earnshaw, B. N. Figgis, and J. Lewis, Chemistry of polynuclear compounds. Part VI. Magnetic properties of trimer chromium and iron carboxylates, J. Chem. Soc. 1656–1663 (1966).
J. S. Striffler, J. S. Law, M. M. Polansky, S. J. Bhathena, and R. A. Anderson, Chromium improves insulin response to glucose in rats, Metabolism
, 1314–1320 (1995).PubMedCrossRef
R. A. Anderson, N. A. Bryden, and M. M. Polansky, Lack of toxicity of chromium chloride and chromium picolinate in rats, J. Am. Coll. Nutr.
, 273–279 (1997).PubMed
D. L. Hasten, M. Hegsted, M. J. Keenan, and G. S. Morris, Effects of various forms of dietary chromium on growth and body composition in the rat, Nutr. Res.
, 283–294 (1997).CrossRef
D. L. Hasten, M. Hegsted, M. J. Keenan, and G. S. Morris, Dosage effects of chromium picolinate on growth and body composition in the rat, Nutr. Res.
, 1175–1186 (1997).CrossRef
G. S. Morris, K. A. Guidry, M. Hegsted, and D. L. Hasten, Effects of dietary chromium supplementation on cardiac mass, metabolic enzymes, and contractile proteins, Nutr. Res.
, 1045–1052 (1995).CrossRef
A. Sclafani, and M. Abrams, Rats show only a weak preference for the artificial sweetener aspartame, Physiol. Behav.
, 253–256 (1986).PubMedCrossRef
J. C. Smith, T. W. Castonguay, D. F. Foster, and L. M. Bloom, A detailed analysis of glucose and saccharin drinking in the rat, Physiol. Behav.
, 173–176 (1980).PubMedCrossRef
B. Beck, A. Burlet, J.-P. Max, and A. Stricker-Krongrad, Effects of long-term ingestion of aspartame on hypothalamic neuropeptide Y, plasma leptin and body weight gain and composition, Physiol. Behav.
, 41–47 (2002).PubMedCrossRef
K. P. Porikas, and H. S. Koopmans, The effect of non-nutritive sweeteners on body weight in rats, Appetite
11(Suppl. 1) 12–15 (1998).
B. J. Rolls, Effects of intense sweeteners on hunger, food intake, and body weight: a review, Am. J. Clin. Nutr.
, 872–878 (1991).PubMed
Y. Sun, K. Mallya, J. Ramirez, and J. B. Vincent, The biomimetic [Cr3
decreases plasma cholesterol and triglycerides in rats: towards chromium-containing therapeutics, J. Biol. Inorg. Chem.
, 838–845 (1999).PubMedCrossRef
Y. Sun, B. J. Clodfelder, A. A. Shute, T. Irvin, and J. B. Vincent, The biomimetic [Cr3
decreases plasma insulin, cholesterol and triglycerides in healthy and type II diabetic rats but not type I diabetic rats, J. Biol. Inorg. Chem.
, 852–862 (2002).PubMedCrossRef
J. K. Speetjens, A. Parand, M. W. Crowder, and J. B. Vincent, Low-molecular-weight chromium-binding substance and biomimetic [Cr3
do not cleave DNA under physiologically relevant conditions, Polyhedron
, 2617–2624 (1999).CrossRef
J. K. Speetjens, R. A. Collins, J. B. Vincent, and S. A. Woksi, The nutritional supplement chromium(III) tris(picolinate) cleaves DNA, Chem. Res. Toxicol.
, 483–487 (1999).PubMedCrossRef
B. Debski, Z. Krejpcio, T. Kuryl, R. Wokciak, and M. Lipko, Biomimetic chromium(III) complex and frutan supplementation affect insulin and membrane glucose transport in rats, J. Trace Elements Exp. Med.
17, 206–207 (2004).
Z. Krejpcio, B. Debski, R. Wojciak, T. Kuryl, and M. Tubacka, Biomimetic chromium(III) complex and fructan supplementation improve blood variables in STZ-induced diabetic rats, J. Trace Elem. Exp. Med.
17, 207–208 (2004).
C. M. Davis, A. C. Royer, and J. B. Vincent, Synthetic multinuclear chromium assembly activates insulin receptor tyrosine kinase activity: functional model for low-molecular-weight chromium-binding substance, Inorg. Chem.
, 5316–5320 (1997).CrossRef
A. A. Shute, and J. B. Vincent, The stability of the biomimetic cation triaqua-μ-oxohexa-propionatotrichromium(III) in vivo in rats, Polyhedron
, 2241–2252 (2001).CrossRef
A. A. Shute, and J. B. Vincent, The fate of the biomimetic cation triaqua-μ-oxohexapro-pionatotrichromium(III) in rats, J. Inorg. Biochem.
, 272–282 (2002).PubMedCrossRef